Jul 1, 2013 · Nonalcoholic fatty liver disease is characterized by excessive fat accumulation in the liver (hepatic steatosis). Nonalcoholic steatohepatitis is characterized by steatosis, liver cell...

Nonalcoholic Fatty Liver Disease (NAFLD) is initially suspected when blood tests show elevated levels of liver enzymes and tests for hepatitis B, C, and autoimmune liver disease are negative …

The term NAFLD actually refers to a group of related liver conditions, including simple fatty liver (i.e. steatosis), non-alcoholic steatohepatitis (steatosis with liver damage/NASH), fatty liver …

This guidance provides a data-supported approach to the diagnostic, therapeutic, and preventive aspects of nonalcoholic fatty liver disease (NAFLD) care. “Guidance” document is different …

Here are the key recommendations for blood testing and referral developed by AACE and cosponsored by AASLD.1. The FIB-4 index is the preferred noninvasive initial test to assess …

NAFLD is a spectrum of disease, defined as a population in which ≥5% of hepatocytes display macrovascular steatosis, in the absence of alternative causes in individuals who drink little/no …

Algorithm for the evaluation of patients at risk for or with established NAFLD across practice settings. Patients with steatosis noted on imaging or for whom there is a clinical suspicion of …

In this review, we will critically analyse both the converging and diverging points in the current clinical guidelines of NAFLD, with a particular focus on the diagnostic and therapeutic aspects.

This guideline provides evidence-based recommendations regarding the diagnosis and management of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis …

Screening and Treatment Algorithm for Nonalcoholic Fatty Liver Disease in Primary Care Clinics. Although the gold standard for diagnosing NAFLD and NASH with and without fibrosis is liver …